前往化源商城

3-(PYRIDIN-2-YLSULFONYL)-N-(4-(TRIFLUOROMETHYL)PHENYL)-8-AZABICYCLO[3.2.1]OCTANE-8-CARBOXAMIDE

更新时间:2025-08-24 17:16:58

3-(PYRIDIN-2-YLSULFONYL)-N-(4-(TRIFLUOROMETHYL)PHENYL)-8-AZABICYCLO[3.2.1]OCTANE-8-CARBOXAMIDE结构式
3-(PYRIDIN-2-YLSULFONYL)-N-(4-(TRIFLUOROMETHYL)PHENYL)-8-AZABICYCLO[3.2.1]OCTANE-8-CARBOXAMIDE结构式
品牌特惠专场
常用名 3-(PYRIDIN-2-YLSULFONYL)-N-(4-(TRIFLUOROMETHYL)PHENYL)-8-AZABICYCLO[3.2.1]OCTANE-8-CARBOXAMIDE 英文名 3-(PYRIDIN-2-YLSULFONYL)-N-(4-(TRIFLUOROMETHYL)PHENYL)-8-AZABICYCLO[3.2.1]OCTANE-8-CARBOXAMIDE
CAS号 1170321-92-2 分子量 439.45
密度 N/A 沸点 N/A
分子式 C20H20F3N3O3S 熔点 N/A
MSDS N/A 闪点 N/A

 用途


ELOVL6-IN-4是一种强效、选择性和口服活性的长链脂肪酸延长酶6(ELOVL6)抑制剂,对人和小鼠ELOVL6的IC50分别为79nM和94nM。相对于其他人类ELOVL亚型(ELOVL1、-2、-3和-5)和小鼠ELOVL3[1],ELOVL6-IN-4显示出优异的选择性。

 名称

英文名 3-pyridin-2-ylsulfonyl-N-[4-(trifluoromethyl)phenyl]-8-azabicyclo[3.2.1]octane-8-carboxamide

 生物活性

描述 ELOVL6-IN-4是一种强效、选择性和口服活性的长链脂肪酸延长酶6(ELOVL6)抑制剂,对人和小鼠ELOVL6的IC50分别为79nM和94nM。相对于其他人类ELOVL亚型(ELOVL1、-2、-3和-5)和小鼠ELOVL3[1],ELOVL6-IN-4显示出优异的选择性。
相关类别
体外研究 ELOVL6-IN-4(化合物 1w)有效降低小鼠肝细胞 H2.35的伸长指数,IC50为 30nM
体内研究 ELOVL6-IN-4(化合物 1w1-10mg/kg灌胃,单次)可有效且剂量依赖性地抑制小鼠肝脏的伸长指数[1] 动物模型:雄性C57BL/6J小鼠[1]剂量:1 mg/kg、3 mg/kg和10 mg/kg给药:口服;结果:对小鼠肝脏伸长指数有明显的剂量依赖性抑制作用。
参考文献

[1]. Tsuyoshi Nagase, et al. Synthesis and biological evaluation of a novel 3-sulfonyl-8-azabicyclo[3.2.1]octane class of long chain fatty acid elongase 6 (ELOVL6) inhibitors. J Med Chem. 2009 Jul 23;52(14):4111-4.  

 物理化学性质

分子式 C20H20F3N3O3S
分子量 439.45
精确质量 439.11800
PSA 87.75000
LogP 5.19330
InChIKey WYCGDOXAJCYGEC-UHFFFAOYSA-N
SMILES O=C(Nc1ccc(C(F)(F)F)cc1)N1C2CCC1CC(S(=O)(=O)c1ccccn1)C2

 安全信息

海关编码 2934999090

 海关

海关编码 2934999090
中文概述 2934999090. 其他杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%
申报要素 品名, 成分含量, 用途
Summary 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
本网页内容来自不同专业数据源,如对内容有疑义,欢迎联系service1@chemsrc.com。
相关化合物: 更多...
methyl N-[2-[2-[5-[6-[1-(2-amino-3-methylbutanoyl)-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-2-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-17-yl]-1H-imidazol-2-yl]-5-methylpyrrolidin-1-yl]-1-(2,6-dimethyloxan-4-yl)-2-oxoethyl]carbamate
1110767-63-9
[2-[17-[3,7-Dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoyl]oxy-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] 3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoate
1110767-70-8
1-[3-[[3-(3,5-Difluorophenyl)-2-[(4-methylphenyl)carbamoylamino]propanoyl]amino]-4,9,13,17-tetramethyl-2,6,12,15,18-pentaoxo-5-oxa-1,11,14,17-tetrazatricyclo[17.3.0.07,11]docosan-16-yl]ethyl dihydrogen phosphate
199929-62-9
[9-[[3-(3,5-Difluorophenyl)-2-[[3-(trifluoromethoxy)phenyl]carbamoylamino]propanoyl]amino]-10,15,19-trimethyl-2,8,12,18,21-pentaoxo-11-oxa-1,7,17,20-tetrazatetracyclo[20.4.0.03,7.013,17]hexacosan-5-yl] dihydrogen phosphate
1175127-67-9
2-iodoethyl N-[1-[2-[6-[11-[2-[1-[2-(2-fluoroethoxycarbonylamino)-3-methylbutanoyl]-2,3,3a,4,5,6,7,7a-octahydroindol-2-yl]-3H-benzimidazol-5-yl]-2-methyl-5-tricyclo[8.2.2.24,7]hexadeca-1(12),4,6,10,13,15-hexaenyl]-1H-benzimidazol-2-yl]-2,3,3a,4,5,6,7,7a-octahydroindol-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate
1401815-79-9
15-Chloro-16,18-dimethyl-12-(2-morpholin-4-yl-2-oxoethoxy)imino-3-oxabicyclo[12.4.0]octadeca-1(14),6,10,15,17-pentaen-2-one;4,16,18-trimethyl-12-(2-oxo-2-piperidin-1-ylethoxy)imino-3-oxabicyclo[12.4.0]octadeca-1(18),6,10,14,16-pentaen-2-one
1266522-99-9
CID 139291212
1186539-74-1
9,18-Dihydroxy-4,16-dimethyl-3-oxabicyclo[12.4.0]octadeca-1(14),6,12,15,17-pentaene-2,8-dione;18-hydroxy-9-[(4-methoxyphenyl)methoxy]-4,16-dimethyl-3-oxabicyclo[12.4.0]octadeca-1(14),6,12,15,17-pentaene-2,8-dione
1400276-57-4
1-(25-Azaoctacyclo[16.13.1.02,16.06,15.09,14.019,24.025,32.026,31]dotriaconta-1(32),2(16),6(15),7,9,11,13,17,19,21,23,26,28,30-tetradecaen-3-yl)-3-benzo[c]carbazol-7-yl-6-methyl-5,6-dihydro-[1]benzothiolo[2,3-c]azocine
1045325-65-2
33-(4,6-Diamino-3,5-dihydroxyoxan-2-yl)oxy-3,5,6,9,11,17-hexahydroxy-15,18-dimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid
1417694-17-7